Updates are available Correction dated 2021-11-24
Click to view Correction: https://doi.org/10.1038/S41467-021-26725-7
-
Authors
Stangherlin, Alessandra http://orcid.org/0000-0001-7296-1183
Watson, Joseph L. http://orcid.org/0000-0001-5492-0249
Wong, David C. S. http://orcid.org/0000-0002-1712-9527
Barbiero, Silvia http://orcid.org/0000-0001-7177-6947
Zeng, Aiwei http://orcid.org/0000-0003-0354-2529
Seinkmane, Estere http://orcid.org/0000-0002-3636-4709
Chew, Sew Peak http://orcid.org/0000-0002-7602-6384
Beale, Andrew D. http://orcid.org/0000-0002-2051-0919
Hayter, Edward A. http://orcid.org/0000-0001-9996-7198
Guna, Alina
Inglis, Alison J.
Putker, Marrit
Bartolami, Eline
Matile, Stefan
Lequeux, Nicolas
Pons, Thomas http://orcid.org/0000-0001-8800-4302
Day, Jason http://orcid.org/0000-0002-3078-0963
van Ooijen, Gerben http://orcid.org/0000-0001-7967-0637
Voorhees, Rebecca M.
Bechtold, David A. http://orcid.org/0000-0001-8676-8704
Derivery, Emmanuel http://orcid.org/0000-0003-3927-5944
Edgar, Rachel S.
Newham, Peter http://orcid.org/0000-0002-0955-4080
O’Neill, John S. http://orcid.org/0000-0003-2204-6096
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MC_UP_1201/4)
- License Information
-
More Information
Article History
Received: 26 May 2020
Accepted: 4 August 2021
First Online: 15 October 2021
Change Date: 24 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/S41467-021-26725-7
Competing interests
: P.N. holds shares in AstraZeneca. The other authors declare no competing interests.
